Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors

W. Ma, F. Giles, X. Zhang, X. Wang, Z. Zhang, T. S. Lee, C. H. Yeh, M. Albitar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint Dive into the research topics of 'Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences